Skip to main content
. 2024 Nov 22;16(11):e74232. doi: 10.7759/cureus.74232

Table 1. Selection criteria of the systematic review.

PRP - platelet-rich plasma, DQVD - De Quervain's disease, DASH - Disabilities of the Arm, Shoulder, and Hand, VAS - Visual analog scoring

Inclusion criteria Exclusion criteria
Use of PRP in the treatment of DQVD and use of quantifiable outcome measures such as ultrasound tendon thickness, DASH, or VAS scoring (or equivalent) to detect treatment efficacy Non-English written manuscript
Unavailability of the full-text manuscript
Review articles
Case reports and case series
Poor quality studies as detailed in the quality assessment section